Puma Biotechnology (PBYI) Current Leases (2019 - 2026)

Puma Biotechnology (PBYI) has 8 years of Current Leases data on file, last reported at $125000.0 in Q1 2026.

• Quarterly Current Leases fell 97.82% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 97.82% YoY) and the FY2025 annual result came in at $1.3 million, down 76.28% from the prior year.
• Current Leases declined to $125000.0 in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $5.7 million in Q1 2025 to a low of $125000.0 in Q1 2026.
• A 5-year average of $4.1 million and a median of $4.4 million in 2025 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2023 — Current Leases grew 16.2% — and 2026, when it sank 97.82%.
• Tracing PBYI's Current Leases over 5 years: stood at $4.1 million in 2022, then advanced by 15.94% to $4.8 million in 2023, then grew by 15.42% to $5.5 million in 2024, then tumbled by 76.28% to $1.3 million in 2025, then tumbled by 90.49% to $125000.0 in 2026.
• The last three Current Leases figures came in at $125000.0 (Q1 2026), $1.3 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.